stroke Tagged Articles
FDA to re-evaluate heart risk data with diabetes drug Avandia
Three years ago, the Food and Drug Administration (FDA) severely restricted the use of GlaxoSmithKline’s (GSK) type 2 diabetes drug Avandia because of concerns about heart attack risks based on an analysis of studies. The move stifled sales of the top-selling diabetes
FDA panel rejects non-hormonal menopause treatment
An experimental non-hormonal treatment for menopause was rejected by a Food and Drug Administration advisory panel this week because the group found risks associated with the drug were greater than any benefit it offered.
Tainted dietary supplements seized by federal agents
Tainted dietary supplements made by Globe All Wellness (Globe All), in Hollywood, Fla., were seized by U.S. Marshals acting on behalf of the Food and Drug Administration (FDA) because the products contain an undisclosed active pharmaceutical ingredient and may be
Yoga helps reduce irregular heartbeat episodes in atrial fibrillation patients
The calming effects of yoga may help reduce the number of irregular heartbeat episodes in patients with a common heart rhythm abnormality known as atrial fibrillation, a new study suggests.
Study: ADHD diagnoses increasing by ‘epidemic proportions’
The prevalence of children diagnosed with attention deficit/hyperactivity disorder (ADHD) in the past decade has reached epidemic proportions in the United States, with diagnoses increasing by nearly 25 percent in that time, according to researchers with the Kaiser Permanente Southern
Experimental diabetes drug tied to heart attacks, strokes, death
An increased risk of heart attacks, strokes and deaths may hurt the chances of Johnson & Johnson’s experimental diabetes drug canagliflozin being approved by the Food and Drug Administration (FDA). Data from nine large patient studies showed the drug raised
Merck seeks approval for previously rejected combination cholesterol drug
Merck & Co. is resubmitting the drug application for its combination cholesterol-lower drug MK-0653C, which was rejected by the Food and Drug Administration (FDA) last March due to insufficient data.
Anti-clotting drug Eliquis gets FDA approval
Eliquis, a new anti-clotting drug developed by Bristol-Myers Squibb and Pfizer as an alternative to the decades-old warfarin (Coumadin), has finally won approval from the U.S. Food and Drug Administration (FDA).
Secretary of State Hillary Clinton taking blood thinners for blood clot
Secretary of State Hillary Clinton is taking anticoagulants to treat a blood clot that developed after she suffered a concussion from a fall. The blood clot is in her head, but doctors say they expect her to make a full recovery.